Lei Yuxi, Li Xiabin, Fan Fan, Feng Ruiwen, He Junfang, Zhong Jing, Zeng Fancai, Tang Yan
Chongqing Yuzhong District Center for Disease Control and Prevention, Chongqing, 400000, China.
School of Public Health, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Eur J Med Res. 2025 Jul 9;30(1):597. doi: 10.1186/s40001-025-02807-w.
To study the effects of ERCC1 and NGFR on metastasis and prognosis of basal-like breast cancer, and construct a prognostic prediction model, initially to explore whether ERCC1 plays a role in BLBC metastasis through NGFR.
RNA-seq was used to identify the metastasis-related gene NGFR associated with ERCC1. ERCC1 and NGFR were transfected into BLBC cells, then western blot and transwell assays were applied to explore the effects of ERCC1 and NGFR on the migratory/invasive abilities and whether ERCC1 plays a role in BLBC cell metastasis through the NGFR. Data from the TCGA database were used to analyze the relationship between NGFR and ERCC1 expression in BLBC patients. The effects of ERCC1 and NGFR on the prognosis were analysed using K-M survival curves and multifactorial Cox regression, and a prognostic prediction model was constructed.
RNA-seq results showed that NGFR was a differentially expressed gene of ERCC1, and NGFR was associated with ERCC1.After knockdown of ERCC1, the migratory and invasive abilities of cancer cells were significantly reduced; after overexpression of NGFR, the migratory and invasive abilities of cancer cells were significantly enhanced. In ERCC1 knockdown cancer cells, the expression levels of NGFR were subsequently reduced, and overexpression of NGFR resulted in an increase in migrating and invading cells and a rebound in migration and invasion capacity. NGFR was positively correlated with ERCC1 expression levels in BLBC patients (r = 0.24, P < 0.05). The overall survival of patients in the group with high expression of ERCC1 and NGFR was shorter. High expression of ERCC1 (HR = 2.310, 95% CI 1.008 ~ 5.293) and NGFR (HR = 2.600, 95% CI 1.126 ~ 6.002) were independent risk factor for poor outcome. The prognostic prediction model's C-index was 0.781, and the AUC values of 3-year and 5-year survival were 0.76, 0.81, and the calibration curves for 3-year and 5-year survival were close to the reference line. The accuracy of the model was similarly validated in the METABRIC dataset.
A positive correlation was observed between ERCC1 and NGFR. ERCC1 may affect the migration and invasion ability of BLBC cells through NGFR; ERCC1 and NGFR were independent risk factors for the poor prognosis of BLBC patients and had a predictive effect on the 3-year and 5-year prognosis of BLBC.
研究ERCC1和NGFR对基底样乳腺癌转移及预后的影响,构建预后预测模型,初步探索ERCC1是否通过NGFR在基底样乳腺癌转移中发挥作用。
采用RNA测序鉴定与ERCC1相关的转移相关基因NGFR。将ERCC1和NGFR转染至基底样乳腺癌细胞中,然后应用蛋白质免疫印迹法和Transwell实验,以探究ERCC1和NGFR对迁移/侵袭能力的影响,以及ERCC1是否通过NGFR在基底样乳腺癌细胞转移中发挥作用。利用TCGA数据库的数据,分析基底样乳腺癌患者中NGFR与ERCC1表达之间的关系。采用K-M生存曲线和多因素Cox回归分析ERCC1和NGFR对预后的影响,并构建预后预测模型。
RNA测序结果显示,NGFR是ERCC1的差异表达基因,且NGFR与ERCC1相关。敲低ERCC1后,癌细胞的迁移和侵袭能力显著降低;过表达NGFR后,癌细胞的迁移和侵袭能力显著增强。在敲低ERCC1的癌细胞中,NGFR的表达水平随后降低,而过表达NGFR导致迁移和侵袭细胞增多,迁移和侵袭能力反弹。在基底样乳腺癌患者中,NGFR与ERCC1表达水平呈正相关(r = 0.24,P < 0.05)。ERCC1和NGFR高表达组患者的总生存期较短。ERCC1高表达(HR = 2.310,95%CI 1.008~5.293)和NGFR高表达(HR = 2.600,95%CI 1.126~6.002)是不良预后的独立危险因素。预后预测模型的C指数为0.781,3年和5年生存率的AUC值分别为0.76、0.81,3年和5年生存率的校准曲线接近参考线。该模型的准确性在METABRIC数据集中也得到了类似验证。
观察到ERCC1与NGFR之间呈正相关。ERCC1可能通过NGFR影响基底样乳腺癌细胞的迁移和侵袭能力;ERCC1和NGFR是基底样乳腺癌患者预后不良的独立危险因素,对基底样乳腺癌患者的3年和5年预后具有预测作用。